Northern Trust’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDTX
Northern Trust's BDTX Position: Q3 2026 in Review
Northern Trust reduced its Black Diamond Therapeutics (BDTX) stake by 1.1% in Q3 2026, selling an estimated $7.53K and leaving 361,550 shares worth $682K. The position accounts for ﹤0.01% of the portfolio, ranked #3556.
Northern Trust first reported a position in BDTX in Q1 2020 and has held it in 27 quarters since. The position peaked at $6.54M in Q4 2020. 111 funds tracked by Wall St. Rank hold BDTX as of Q3 2026.
- Northern Trust held 361,550 shares of Black Diamond Therapeutics worth $682K as of Q3 2026.
- Northern Trust sold 3,844 Black Diamond Therapeutics shares in Q3 2026, an estimated $7.53K.
- Black Diamond Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #3556 holding.
- Northern Trust first reported a position in Black Diamond Therapeutics in Q1 2020 and has held it in 27 quarters since.
- Northern Trust's Black Diamond Therapeutics position peaked at $6.54M in Q4 2020.
- 111 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.